(Ph.D.) 2000 ~ 2004 Ph.D., University of Southern California, Pathology
Journal Articles
(2023)
Mechanistic insights into the dual role of CCAR2/DBC1 in cancer.
EXPERIMENTAL AND MOLECULAR MEDICINE.
55,
8
(2022)
DBC1 is a key positive regulator of enhancer epigenomic writers KMT2D and p300.
NUCLEIC ACIDS RESEARCH.
50,
14
(2021)
Sequence variants in the proximal promoter and+5.8-kb site of ABO in Koreans with weak B phenotypes.
VOX SANGUINIS.
epub,
epub
(2021)
Bruceantin targets HSP90 to overcome resistance to hormone therapy in castration-resistant prostate cancer.
THERANOSTICS.
11,
2
(2020)
Medicinal Activities and Nanomedicine Delivery Strategies for Brucea javanica Oil and Its Molecular Components.
MOLECULES.
25,
22
(2019)
Detection of circulating tumor cells and their potential use as a biomarker for advanced renal cell carcinoma.
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL.
13,
9
(2018)
DBC1 regulates Wnt/beta-catenin-mediated expression of MACC1, a key regulator of cancer progression, in colon cancer.
CELL DEATH & DISEASE.
9,
8
(2018)
DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7.
ONCOGENE.
37,
10
(2018)
DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7..
ONCOGENE.
37,
10
(2016)
Immunohistochemical staining of ERG and SOX9 as potential biomarkers of docetaxel response in patients with metastatic castration-resistant prostate cancer.
ONCOTARGET.
7,
50
(2016)
Positive regulation of beta-catenin-PROX1 signaling axis by DBC1 in colon cancer progression.
ONCOGENE.
35,
26
(2016)
Expression of DBC1 is associated with poor prognosis in hepatitis virus-related hepatocellular carcinoma.
PATHOLOGY RESEARCH AND PRACTICE.
212,
7
(2016)
The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
CANCER RESEARCH AND TREATMENT.
48,
3
(2015)
Positive regulation of β-catenin-PROX1 signaling axis by DBC1 in colon cancer progression.
ONCOGENE.
Epub,
Epub
(2015)
The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis.
CANCER RESEARCH AND TREATMENT.
Epub,
Epub
(2015)
A positive role of DBC1 in PEA3-mediated progression of estrogen receptor-negative breast cancer.
ONCOGENE.
34,
34
(2014)
A positive role of DBC1 in PEA3-mediated progression of estrogen receptor-negative breast cancer.
ONCOGENE.
epub,
epub
(2014)
The prognostic significance of Smad3, Smad4, Smad3 phosphoisoform expression in esophageal squamous cell carcinoma.
MEDICAL ONCOLOGY.
31,
11
(2014)
ZNF282 (Zinc finger protein 282), a novel E2F1 co-activator, promotes esophageal squamous cell carcinoma.
ONCOTARGET.
5,
23
(2014)
Overexpression of integrin alpha v correlates with poor prognosis in colorectal cancer.
JOURNAL OF CLINICAL PATHOLOGY.
67,
7
Patent/Intellectual Property
브루세안틴(Bruceantin) 및 나노입자를 포함하는 거세 저항성 전립선암 치료용 약학적 조성물(A pharmaceutical composition for treating castration-resistant prostate cancer comprising bruceantin and nanoparticles).
10-2626-6930000.
20240115.
KOREA, REPUBLIC OF
Conference Paper
(2022)
DBC1 is a key positive regulator of enhancer epigenomic writers KMT2D and p300.
2022년도 KSMCB 에피유전체학분과 심포지엄.
KOREA, REPUBLIC OF
(2022)
Role of DBC1 in the regulation of histone H3 acetylation and methylation.
KSBMB International Conference 2022.
KOREA, REPUBLIC OF
(2017)
DBC1, a regulator of nuclear receptors and epigenetic modifiers.
2017년 KSMCB 에피유전체학분과 심포지움.
KOREA, REPUBLIC OF
(2017)
DBC1 promotes castration-resistant prostate cancer by positively regulating DNA binding and stability of AR-V7.
2017년 대한전립선학회,대한비뇨기종양학회,비뇨기계기초의학연구회 공동심포지움.
KOREA, REPUBLIC OF
(2014)
Regulation of PEA3 acetylation by DBC1.
The 21st East Asia Joint Symposium on Biomedical Research.
KOREA, REPUBLIC OF
(2012)
SUMOylation of ZFP282 potentiates its positive effect on estrogen signaling in breast tumorigenesis.
2012년도 한국분자세포생물학회 정기학술대회.
KOREA, REPUBLIC OF
